ELAN in the 13F filings
Elanco Animal Health Inc · CUSIP 28414H103
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 6 listed it in both
- Shares listed
- 147,395,182
- combined, among listed positions
- Reported value
- $3.5bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 15 buyers (opened or added shares) and 16 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -12,245,772.
Managers listing ELAN in Q1 2026
24 of 24 holders
Largest increases and reductions, by shares
Increases
- Invesco Ltdexisting position · 8,141,172 shares now+3,352,135
- Wellington Management Group LLPexisting position · 3,035,856 shares now+1,645,011
- Marshall Wace LLPnew position · 1,382,412 shares now+1,382,412
- Capital World Investorsexisting position · 3,408,331 shares now+1,329,443
- Citadel Advisors LLCexisting position · 4,387,127 shares now+689,001
Reductions
- Dodge & Coxexisting position · 68,944,100 shares now-10,140,205
- Millennium Management LLCexisting position · 714,039 shares now-7,408,568
- Fidelity (FMR LLC)existing position · 50,925,366 shares now-1,270,955
- ExodusPoint Capital Management LPexisting position · 570,032 shares now-193,299
- Verition Fund Management LLCexisting position · 211,287 shares now-112,662
New positions and exits
New (3)
Exited (7)
- Balyasny Asset Management LLCwas $25m
- Steadfast Capital Management LPwas $11m
- Woodline Partners LPwas $10m
- Holocene Advisors LPwas $7.5m
- Squarepoint Ops LLCwas $6.2m
- Man Group PLCwas $1.5m
- Tudor Investment Corpwas $661k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2018 | 13 | $388m | n.a. | n.a. |
| Q4 2018 | 7 | $383m | n.a. | n.a. |
| Q1 2019 | 14 | $3.5bn | n.a. | n.a. |
| Q2 2019 | 10 | $3.7bn | n.a. | n.a. |
| Q3 2019 | 13 | $2.9bn | n.a. | n.a. |
| Q4 2019 | 13 | $3.3bn | n.a. | n.a. |
| Q1 2020 | 13 | $2.9bn | n.a. | n.a. |
| Q2 2020 | 12 | $2.4bn | n.a. | n.a. |
| Q3 2020 | 6 | $2.9bn | n.a. | n.a. |
| Q4 2020 | 16 | $4.1bn | n.a. | n.a. |
| Q1 2021 | 12 | $4.0bn | n.a. | n.a. |
| Q2 2021 | 14 | $4.6bn | n.a. | n.a. |
| Q3 2021 | 10 | $4.0bn | n.a. | n.a. |
| Q4 2021 | 13 | $3.8bn | n.a. | n.a. |
| Q1 2022 | 11 | $3.1bn | n.a. | n.a. |
| Q2 2022 | 11 | $2.4bn | n.a. | n.a. |
| Q3 2022 | 15 | $1.9bn | n.a. | n.a. |
| Q4 2022 | 15 | $1.7bn | n.a. | n.a. |
| Q1 2023 | 12 | $1.2bn | n.a. | n.a. |
| Q2 2023 | 13 | $1.6bn | n.a. | n.a. |
| Q3 2023 | 12 | $1.7bn | n.a. | n.a. |
| Q4 2023 | 9 | $1.9bn | 2 | 9 |
| Q1 2024 | 10 | $2.3bn | 7 | 3 |
| Q2 2024 | 9 | $2.1bn | 6 | 4 |
| Q3 2024 | 7 | $1.5bn | 4 | 3 |
| Q4 2024 | 5 | $1.5bn | 2 | 2 |
| Q1 2025 | 6 | $1.5bn | 4 | 1 |
| Q2 2025 | 9 | $2.5bn | 8 | 2 |
| Q3 2025 | 12 | $3.4bn | 7 | 5 |
| Q4 2025 | 9 | $3.3bn | 17 | 15 |
| Q1 2026 | 5 | $3.0bn | 15 | 16 |
| Q2 2026 | 10 | $3.6bn | 15 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ELAN and LLY →ELAN and JNJ →ELAN and VRTX →Choose a stock to compare with ELAN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ELAN, latest filings →Back to the 13F Explorer →